Literature DB >> 12768019

Human cytomegalovirus infection inhibits tumor necrosis factor alpha (TNF-alpha) signaling by targeting the 55-kilodalton TNF-alpha receptor.

J Baillie1, D A Sahlender, J H Sinclair.   

Abstract

Infection with human cytomegalovirus (HCMV) results in complex interactions between viral and cellular factors which perturb many cellular functions. HCMV is known to target the cell cycle, cellular transcription, and immunoregulation, and it is believed that this optimizes the cellular environment for viral DNA replication during productive infection or during carriage in the latently infected host. Here, we show that HCMV infection also prevents external signaling to the cell by disrupting the function of TNFRI, the 55-kDa receptor for tumor necrosis factor alpha (TNF-alpha), one of the receptors for a potent cytokine involved in eliciting a wide spectrum of cellular responses, including antiviral responses. HCMV infection of fully permissive differentiated monocytic cell lines and U373 cells resulted in a reduction in cell surface expression of TNFRI. The reduction appeared to be due to relocalization of TNFRI from the cell surface and was reflected in the elimination of TNF-alpha-induced Jun kinase activity. Analysis of specific phases of infection suggested that viral early gene products were responsible for this relocalization. However, a mutant HCMV in which all viral gene products known to be involved in down-regulation of major histocompatibility complex (MHC) class I were deleted still resulted in relocalization of TNFRI. Consequently, TNFRI relocalization by HCMV appears to be mediated by a novel viral early function not involved in down-regulation of cell surface MHC class I expression. We suggest that upon infection, HCMV isolates the cell from host-mediated signals, forcing the cell to respond only to virus-specific signals which optimize the cell for virus production and effect proviral responses from bystander cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12768019      PMCID: PMC156201          DOI: 10.1128/jvi.77.12.7007-7016.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules.

Authors:  Y Jun; E Kim; M Jin; H C Sung; H Han; D E Geraghty; K Ahn
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

2.  A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2.

Authors:  V S Goldmacher; L M Bartle; A Skaletskaya; C A Dionne; N L Kedersha; C A Vater; J W Han; R J Lutz; S Watanabe; E D Cahir McFarland; E D Kieff; E S Mocarski; T Chittenden
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

3.  Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus.

Authors:  C A Benedict; K D Butrovich; N S Lurain; J Corbeil; I Rooney; P Schneider; J Tschopp; C F Ware
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

4.  Stimulatory and inhibitory action of cytokines on the regulation of hCMV-IE promoter activity in human endothelial cells.

Authors:  T Ritter; C Brandt; S Prösch; A Vergopoulos; K Vogt; J Kolls; H D Volk
Journal:  Cytokine       Date:  2000-08       Impact factor: 3.861

Review 5.  Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus.

Authors:  E A Fortunato; A K McElroy; I Sanchez; D H Spector
Journal:  Trends Microbiol       Date:  2000-03       Impact factor: 17.079

6.  Activation of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: a novel mechanism for activation of p38.

Authors:  R A Johnson; S M Huong; E S Huang
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

7.  Accumulation of virion tegument and envelope proteins in a stable cytoplasmic compartment during human cytomegalovirus replication: characterization of a potential site of virus assembly.

Authors:  V Sanchez; K D Greis; E Sztul; W J Britt
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

8.  Decreased cytomegalovirus expression following proinflammatory cytokine treatment of primary human astrocytes.

Authors:  M C Cheeran; S Hu; G Gekker; J R Lokensgard
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

9.  Human cytomegalovirus mediates cell cycle progression through G(1) into early S phase in terminally differentiated cells.

Authors:  J Sinclair; J Baillie; L Bryant; R Caswell
Journal:  J Gen Virol       Date:  2000-06       Impact factor: 3.891

10.  Human cytomegalovirus infection inhibits epidermal growth factor (EGF) signalling by targeting EGF receptors.

Authors:  J A Fairley; J Baillie; M Bain; J H Sinclair
Journal:  J Gen Virol       Date:  2002-11       Impact factor: 3.891

View more
  43 in total

Review 1.  Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything.

Authors:  A Loewendorf; C A Benedict
Journal:  J Intern Med       Date:  2010-05       Impact factor: 8.989

2.  The latency-associated UL138 gene product of human cytomegalovirus sensitizes cells to tumor necrosis factor alpha (TNF-alpha) signaling by upregulating TNF-alpha receptor 1 cell surface expression.

Authors:  Christina Montag; Jutta Annabella Wagner; Iris Gruska; Barbara Vetter; Lüder Wiebusch; Christian Hagemeier
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

3.  The human cytomegalovirus UL36 gene controls caspase-dependent and -independent cell death programs activated by infection of monocytes differentiating to macrophages.

Authors:  A Louise McCormick; Linda Roback; Devon Livingston-Rosanoff; Courtney St Clair
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

4.  Adenovirus RIDalphabeta complex inhibits lipopolysaccharide signaling without altering TLR4 cell surface expression.

Authors:  Fernando Delgado-Lopez; Marshall S Horwitz
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Identification of TRIM23 as a cofactor involved in the regulation of NF-kappaB by human cytomegalovirus.

Authors:  Emma Poole; Ian Groves; Andrew MacDonald; Yin Pang; Antonio Alcami; John Sinclair
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

6.  NF-kappaB-mediated activation of the chemokine CCL22 by the product of the human cytomegalovirus gene UL144 escapes regulation by viral IE86.

Authors:  Emma Poole; Elizabeth Atkins; Takashi Nakayama; Osamu Yoshie; Ian Groves; Antonio Alcami; John Sinclair
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

Review 7.  Chronic viral infection and primary central nervous system malignancy.

Authors:  Robert Saddawi-Konefka; John R Crawford
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

Review 8.  Innate immunity regulates adaptive immune response: lessons learned from studying the interplay between NK and CD8+ T cells during MCMV infection.

Authors:  Maja Mitrović; Jurica Arapović; Luka Traven; Astrid Krmpotić; Stipan Jonjić
Journal:  Med Microbiol Immunol       Date:  2012-09-11       Impact factor: 3.402

9.  Epstein-Barr virus immediate-early protein BZLF1 inhibits tumor necrosis factor alpha-induced signaling and apoptosis by downregulating tumor necrosis factor receptor 1.

Authors:  Thomas E Morrison; Amy Mauser; Aloysius Klingelhutz; Shannon C Kenney
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

10.  Murine cytomegalovirus infection inhibits tumor necrosis factor alpha responses in primary macrophages.

Authors:  Daniel L Popkin; Herbert W Virgin
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.